Reduction of the scopolamine-induced impairment of passive-avoidance performance by σ receptor agonist in mice

Physiology and Behavior

Volumn 61, Issue 2, 1997, Pages 257-264

  Senda, Toshihiko ^a   Matsuno, Kiyoshi ^a   Kobayashi, Tetsuya ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

(+) SKF 10,047; (+)3 PPP; ( ) SKF 10,047; DTG; Mice; Passive avoidance performance; Scopolamine; Receptor agonists; 1 Receptor subtype

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; HALOPERIDOL; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N ALLYLNORMETAZOCINE; OPIATE; PHYSOSTIGMINE; PRECLAMOL; RECEPTOR SUBTYPE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STEREOISOMERISM;

EID: 0031045754     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(96)00447-7     Document Type: Article

References (35)

1. Becker R. Therapy of the cognitive deficit in Alzheimer's disease: the cholinergic system. Becker R., Giacobini E. Cholinergic basis for Alzheimer therapy. 1991;1-22 Birkhauser, Boston.
2. 1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251:1994;R1-R2.
3. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N. Engl. J. Med. 327:1992;1253-1259.
4. Deutsch J. A. The cholinergic synapse and the site of memory. Deutsch J. A. The physiological basis of memory. 1983;367-386 Academic Press, New York.
5. Dokla C. P. J., Parker S. C., Thal L. J. Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalis magnocellularis lesions. Neuropharmacology. 28:1989;1279-1282.
6. Ferris C. D., Hirsch D. J., Brooks B. P., Snyder S. H. σ Receptors: from molecule to man. J. Neurochem. 57:1991;729-737.
7. Hellewell S. B., Bowen W. D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527:1990;244-253.
8. Itzhak Y. Multiple sigma binding sites in the brain. Itzhak Y. Sigma receptors. 1994;113-137 Academic Press, San Diego.
9. Junien J. L., Gue M., Pascaud X., Fioramonti J., Bueno L. Selective stimulation of colonic motor response to a meal by σ ligands in dogs. Gastroenterology. 99:1990;684-689.
10. 3H]acetylcholine release from rat hippocampal slices. Eur. J. Pharmacol. 200:1991;343-345.
11. Kobayashi T., Matsuno K., Mita S. Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain. J. Neural Transm. 103:1996;661-669.
12. Matsuno K., Matsunaga K., Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res. 575:1992;315-319.
13. Matsuno K., Matsunaga K., Senda T., Mita S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J. Pharmacol. Exp. Ther. 265:1993;851-859.
14. 2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Psychopharmacology. 112:1993;134-141.
15. Matsuno K., Senda T., Matsunaga K., Mita S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central cholinergic system. Eur. J. Pharmacol. 261:1994;43-51.
16. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res. 690:1995;200-206.
17. 1 receptor agonistic properties. Behav. Brain Res. (in press).
18. 1 receptor agonist. Eur. J. Pharmacol. 306:1996;271-279.
19. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647:1994;44-56.
20. Maurice T., Hiramatsu M., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia. Brain Res. 647:1994;57-64.
21. Nabeshima T., Yoshida S., Kameyama T. Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice. Eur. J. Pharmacol. 154:1988;263-269.
22. Okuyama S., Imagawa Y., Ogawa S., Araki H., Ajima A., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M., Otomo S. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 53:1994;285-290.
23. Pascaud X., Defaux J. P., Roze C., Junien J. L. Effect of selective sigma ligands on duodenal alkaline secretion in the rat. J. Pharmacol. Exp. Ther. 255:1990;1354-1359.
24. Quirion R., Bowen W. D., Itzhak Y., Junien J. L., Musacchio J. M., Rothman R. B., Su T-P., Tam S. W., Taylor D. P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
25. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers:from indiscriminate to valid testing: Part I. Psychopharmacology. 107:1992;144-159.
26. Seiden L. S., Dykstra L. A. Pharmacolgical and biochemical aspects of learning and memory. Seiden L. S., Dykstra L. A. Psychopharmacology: A biochemical and behavioral approach. 1977;243-279 Van Nostrand Reinhold Company, New York.
27. Siniscalchi A., Cristofori P., Veratti E. Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn-Schmied. Arch. Pharmacol. 336:1987;425-429.
28. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res. Rev. 13:1988;103-118.
29. Steinfels G. F., Alberici G. P., Tam S. W., Cook L. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine. Neuropsychopharmacology. 1:1988;321-327.
30. Su T-P. σ Receptors, putative links between nervous, endocrine and immune systems. Eur. J. Biochem. 200:1991;633-642.
31. Su T-P., Wu X-Z., Spivak C. E., London E. D., Bell J. A. Binding sites on intact NCB-20 cells suggest sigma receptor multiplicity: sigma1 and sigma2. Kameyama T., Nabeshima T., Domino E. F. NMDA receptor related agents: Biochemistry, pharmacology and behavior. 1991;227-233 NPP Books, Ann Arbor.
32. Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., King A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315:1986;1241-1245.
33. Tam S. W., Steinfels G. F., Cook L. Biochemical and behavioral aspects of sigma and phencyclidine receptors: Similarities and differences. Domino E. F., Kamenka J. M. Sigma and phencyclidine-like compounds as molecular probes in biology. 1988;383-396 NPP Books, Ann Arbor.
34. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., DeCosta B., Rice K. C. Sigma receptors: biology and function. Pharmacol. Rev. 42:1990;355-402.
35. Zhou G-Z., Musacchio J. M. Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain. Eur. J. Pharmacol. Mol. Pharmacol. 206:1991;261-269.